Efficacy and Safety of Evolocumab in Chinese Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia: 12-Week Primary Results of the HUA TUO 华佗 Randomized Clinical Trial

被引：0
|
作者：
Hong Tan
Weimin Li
Zhouqing Huang
Yajun Han
Xuecheng Huang
Dongye Li
Xiaochun Xing
Maria Laura Monsalvo
You Wu
Jackie Mao
Lily Xin
Jiyan Chen
机构：
[1] Guangdong Provincial People’s Hospital,
[2] The First Affiliated Hospital of Harbin Medical University,undefined
[3] The First Affiliated Hospital of Wenzhou Medical University,undefined
[4] Inner Mongolia Autonomous Region People’s Hospital,undefined
[5] The Second Nanning People’s Hospital,undefined
[6] The Affiliated Hospital of Xuzhou Medical University,undefined
[7] Tianjin Fourth Central Hospital,undefined
[8] Amgen Inc.,undefined
[9] Amgen China,undefined
来源：
Cardiology and Therapy | 2023年 / 12卷
关键词：
Evolocumab; Hypercholesterolemia; Mixed dyslipidemia; LDL cholesterol; PCSK9; Hyperlipidemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：341 / 359
页数：18
相关论文
共 14 条
  • [1] Efficacy and Safety of Evolocumab in Chinese Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia: 12-Week Primary Results of the HUA TUO (sic) Randomized Clinical Trial
    Tan, Hong
    Li, Weimin
    Huang, Zhouqing
    Han, Yajun
    Huang, Xuecheng
    Li, Dongye
    Xing, Xiaochun
    Monsalvo, Maria Laura
    Wu, You
    Mao, Jackie
    Xin, Lily
    Chen, Jiyan
    CARDIOLOGY AND THERAPY, 2023, 12 (02) : 341 - 359
  • [2] Efficacy and Safety of Ongericimab in Chinese Patients With Primary Hypercholesterolemia and Mixed Dyslipidemia
    Wang, Xiaozeng
    Qiu, Miaohan
    Cheng, Zhifeng
    Ji, Xianyou
    Chen, Jiyan
    Zhu, Hong
    Tang, Yida
    Huang, Zhouqing
    Su, Guohai
    Wang, Gaopin
    Huang, Zhijun
    Yao, Zhuhua
    Lin, Jinxiu
    Sun, Yihong
    Li, Shunhui
    Shao, Cong
    Zhao, Yi
    Bai, Xuelian
    Han, Yaling
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (11):
  • [3] Efficacy and Safety of Ongericimab in Chinese Patients With Primary Hypercholesterolemia and Mixed Dyslipidemia
    Wang, Xiaozeng
    Qiu Miaohan
    Cheng, Zhifeng
    Ji, Xianyou
    Chen, Jiyan
    Zhu, Hong
    Tang, Yida
    Huang, Zhouqing
    Su, Guohai
    Wang, Gaopin
    Huang, Zhijun
    Yao, Zhuhua
    Lin, Jinxiu
    Sun, Yihong
    Li, Shunhui
    Shao, Cong
    Yan, Hui
    Zhao, Yi
    Bai, Xuelian
    Wang, Shi
    Han Yaling
    CIRCULATION, 2023, 148
  • [4] Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: The BERSON clinical trial
    Lorenzatti, Alberto J.
    Eliaschewitz, Freddy G.
    Chen, Yundai
    Fialkow, Jonathan
    Lu, Juming
    Baass, Alexis
    Monsalvo, Maria Laura
    Hsu, Hui-Chun
    Somaratne, Ransi
    Ge, Junbo
    CLINICAL CARDIOLOGY, 2018, 41 (09) : 1117 - 1122
  • [5] Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies
    Jones, Peter H.
    Davidson, Michael H.
    Goldberg, Anne C.
    Pepine, Carl J.
    Kelly, Maureen T.
    Buttler, Susan M.
    Setze, Carolyn M.
    Lele, Aditya
    Sleep, Darryl J.
    Stolzenbach, James C.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2009, 3 (02) : 125 - 137
  • [6] Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial
    Melani, L
    Mills, R
    Hassman, D
    Lipetz, R
    Lipka, L
    LeBeaut, A
    Suresh, R
    Mukhopadhyay, P
    Veltri, E
    EUROPEAN HEART JOURNAL, 2003, 24 (08) : 717 - 728
  • [7] Efficacy and safety of ursodeoxycholic acid in primary, type IIa or IIb hypercholesterolemia: A multicenter, randomized, double-blind clinical trial
    Braga, Manoela F. B.
    Grace, Michael G. A.
    Lenis, Jacques
    Kennedy, Frank P.
    Teplinsky, Avery L.
    Roederer, Ghislaine
    Palumbo, Pasquale J.
    Colin, Patrick
    Leiter, Lawrence A.
    ATHEROSCLEROSIS, 2009, 203 (02) : 479 - 482
  • [8] A Randomized, Double-blind, Placebo-controlled Trial to Evaluate Efficacy and Tolerability of an Optimized Botanical Combination in the Management of Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia
    Gupta, H.
    Pawar, D.
    Riva, A.
    Bombardelli, E.
    Morazzoni, P.
    PHYTOTHERAPY RESEARCH, 2012, 26 (02) : 265 - 272
  • [9] A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia
    Saito, Y
    Yamada, N
    Teramoto, T
    Itakura, H
    Hata, Y
    Nakaya, N
    Mabuchi, H
    Tushima, M
    Sasaki, J
    Ogawa, N
    Goto, Y
    ATHEROSCLEROSIS, 2002, 162 (02) : 373 - 379
  • [10] Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial
    Raal, Frederick
    Durst, Ronen
    Bi, Ran
    Talloczy, Zsolt
    Maheux, Pierre
    Lesogor, Anastasia
    Kastelein, John J. P.
    CIRCULATION, 2024, 149 (05) : 354 - 362
12